Healthcare provider profile · identity verified

Sean Vikram Bhatia, MD

Internal Medicine · VANCOUVER, WA · NPI 1386039550

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	531	149
Amlodipine Besylate	Amlodipine Besylate	347	107
Losartan Potassium	Losartan Potassium	318	104
Lisinopril	Lisinopril	288	86
Levothyroxine Sodium	Levothyroxine Sodium	192	50
Rosuvastatin Calcium	Rosuvastatin Calcium	189	55
Tamsulosin Hcl	Tamsulosin Hcl	171	63
Gabapentin	Gabapentin	166	51
Metoprolol Succinate	Metoprolol Succinate	163	49
Duloxetine Hcl	Duloxetine Hcl	159	52
Metoprolol Tartrate	Metoprolol Tartrate	158	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	149	28
Metformin Hcl	Metformin Hcl	149	46
Oxycodone Hcl	Oxycodone Hcl	142	34
Potassium Chloride	Potassium Chloride	137	51
Sertraline Hcl	Sertraline Hcl	134	41
Pradaxa	Dabigatran Etexilate Mesylate	129	42
Pantoprazole Sodium	Pantoprazole Sodium	127	50
Albuterol Sulfate Hfa	Albuterol Sulfate	125	48
Jardiance	Empagliflozin	121	29
Simvastatin	Simvastatin	116	34
Trazodone Hcl	Trazodone Hcl	114	37
Furosemide	Furosemide	109	36
Carvedilol	Carvedilol	104	33
Glipizide	Glipizide	103	31
Metformin Hcl Er	Metformin Hcl	93	29
Allopurinol	Allopurinol	87	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	27
Hydrochlorothiazide	Hydrochlorothiazide	83	29
Pregabalin	Pregabalin	82	20
Terazosin Hcl	Terazosin Hcl	72	16
Finasteride	Finasteride	68	18
Alendronate Sodium	Alendronate Sodium	67	25
Atenolol	Atenolol	63	18
Pravastatin Sodium	Pravastatin Sodium	61	20
Tramadol Hcl	Tramadol Hcl	61	suppressed
Alvesco	Ciclesonide	58	15
Omeprazole	Omeprazole	52	17
Famotidine	Famotidine	50	14
Warfarin Sodium	Warfarin Sodium	49	15
Bupropion Xl	Bupropion Hcl	48	16
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Ozempic	Semaglutide	46	suppressed
Spironolactone	Spironolactone	46	18
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	43	15
Triamcinolone Acetonide	Triamcinolone Acetonide	41	24
Fluticasone Propionate	Fluticasone Propionate	39	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	12
Venlafaxine Hcl Er	Venlafaxine Hcl	38	13
Xarelto	Rivaroxaban	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	37	12
Prednisone	Prednisone	36	30
Buspirone Hcl	Buspirone Hcl	34	14
Wixela Inhub	Fluticasone Propion/Salmeterol	34	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	11
Humulin N	Insulin Nph Human Isophane	32	11
Spiriva Respimat	Tiotropium Bromide	32	14
Fluoxetine Hcl	Fluoxetine Hcl	31	14
Meloxicam	Meloxicam	31	12
Mirtazapine	Mirtazapine	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Torsemide	Torsemide	29	15
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Humulin R	Insulin Regular, Human	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Mometasone Furoate	Mometasone Furoate	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Ondansetron Odt	Ondansetron	22	11
Estradiol	Estradiol	21	11
Memantine Hcl	Memantine Hcl	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	20	20
Azithromycin	Azithromycin	20	19
Clonazepam	Clonazepam	20	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	20	20
Doxycycline Monohydrate	Doxycycline Monohydrate	20	11
Ipratropium Bromide	Ipratropium Bromide	20	15
Divalproex Sodium	Divalproex Sodium	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Nystatin	Nystatin	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Digoxin	Digoxin	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	12
Propranolol Hcl	Propranolol Hcl	15	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Alprazolam	Alprazolam	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Eliquis	Apixaban	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cefadroxil	Cefadroxil	13	13
Chlorthalidone	Chlorthalidone	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	11	11
Trospium Chloride	Trospium Chloride	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error